An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence
Tóm tắt
Burkitt lymphoma (BL) is a highly aggressive, rapidly growing B cell non-Hodgkin lymphoma, which manifests in several subtypes including sporadic, endemic, and immunodeficiency-associated forms. Pathologically, BL is classically characterized by translocations of chromosomes 8 and 14 resulting in upregulation of the c-myc protein transcription factor with upregulation of cell proliferation. BL affects nearly every organ system, most commonly the abdomen and pelvis in the sporadic form. Imaging using a multimodality approach plays a crucial role in the management of BL from diagnosis, staging, and evaluation of treatment response to therapy-related complications with ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography playing roles. In this article, we review the pathobiology and classification of BL, illustrate a multimodality imaging approach in evaluating common and uncommon sites of involvement within the trunk and head and neck, and review common therapies and treatment-related complications.
Tài liệu tham khảo
Mbulaiteye SM, Anderson WF, Ferlay J et al (2012) Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol 87(6):573–578. https://doi.org/10.1002/ajh.23187
Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107(1):265–276. https://doi.org/10.1182/blood-2005-06-2508
Ferry JA (2006) Burkitt’s lymphoma: clinicopathologic features and differential diagnosis. Oncologist 11(4):375–383. https://doi.org/10.1634/theoncologist.11-4-375
Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM (2008) Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 123(11):2658–2663. https://doi.org/10.1002/ijc.23800
Magrath I (2012) Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 156(6):744–756. https://doi.org/10.1111/j.1365-2141.2011.09013.x
Brady G, MacArthur GJ, Farrell PJ (2007) Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol 60(12):1397–1402. https://doi.org/10.1136/jcp.2007.047977
Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM (2014) Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med 4(2). https://doi.org/10.1101/cshperspect.a014282
O’Malley DP, Auerbach A, Weiss LM (2015) Practical applications in immunohistochemistry: evaluation of diffuse large B-cell lymphoma and related large B-cell lymphomas. Arch Pathol Lab Med 139(9):1094–1107. https://doi.org/10.5858/arpa.2014-0451-CP
Sesques P, Johnson NA (2017) Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements. Blood 129(3):280–288. https://doi.org/10.1182/blood-2016-02-636316
Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390. https://doi.org/10.1182/blood-2016-01-643569
Shawker TH, Dunnick NR, Head GL, Magrath IT (1979) Ultrasound evaluation of American Burkitt’s lymphoma. J Clin Ultrasound 7(4):279–283
Biko DM, Anupindi SA, Hernandez A, Kersun L, Bellah R (2009) Childhood Burkitt lymphoma: abdominal and pelvic imaging findings. AJR Am J Roentgenol 192(5):1304–1315. https://doi.org/10.2214/AJR.08.1476
Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL (2011) Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 197(3):W384–W391. https://doi.org/10.2214/AJR.10.5692
Schob S, Meyer J, Gawlitza M et al (2016) Diffusion-weighted MRI reflects proliferative activity in primary CNS lymphoma. PLoS One 11(8):e0161386. https://doi.org/10.1371/journal.pone.0161386
Mayerhoefer ME, Karanikas G, Kletter K et al (2015) Evaluation of diffusion-weighted magnetic resonance imaging for follow-up and treatment response assessment of lymphoma: results of an 18F-FDG-PET/CT-controlled prospective study in 64 patients. Clin Cancer Res 21(11):2506–2513. https://doi.org/10.1158/1078-0432.CCR-14-2454
Albano D, Bosio G, Re A, Pagani C, Giubbini R, Bertagna F (2018) Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET/CT in adult Burkitt’s lymphoma: the role of Deauville and IHP criteria. Leuk Lymphoma:1–8. https://doi.org/10.1080/10428194.2018.1482541
Albano D, Bosio G, Pagani C et al (2019) Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma. Eur J Nucl Med Mol Imaging 46(1):87–96. https://doi.org/10.1007/s00259-018-4173-2
Bailly C, Eugene T, Couec ML et al (2014) Prognostic value and clinical impact of (18) FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med (Lausanne) 1:54. https://doi.org/10.3389/fmed.2014.00054
Carrillo-Cruz E, Marin-Oyaga VA, Sole Rodriguez M et al (2015) Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma. Eur J Haematol 94(1):23–30. https://doi.org/10.1111/ejh.12284
Davidson T, Priel E, Schiby G et al (2018) Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT. Abdom Radiol (NY) 43(9):2369–2374. https://doi.org/10.1007/s00261-017-1454-3
Karantanis D, Durski JM, Lowe VJ et al (2010) 18F-FDG PET and PET/CT in Burkitt’s lymphoma. Eur J Radiol 75(1):e68–e73. https://doi.org/10.1016/j.ejrad.2009.07.035
Wei WX, Huang JJ, Li WY et al (2015) Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt’s lymphoma. Chin J Cancer 34(12):608–613. https://doi.org/10.1186/s40880-015-0057-z
Cheng G, Servaes S, Zhuang H (2013) Value of (18) F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma. Leuk Lymphoma 54(4):737–742. https://doi.org/10.3109/10428194.2012.727416
Heacock L, Weissbrot J, Raad R et al (2015) PET/MRI for the evaluation of patients with lymphoma: initial observations. AJR Am J Roentgenol 204(4):842–848. https://doi.org/10.2214/AJR.14.13181
Zelenetz A, Gordon L, J. A, A. R (2018) NCCN clinical practice guidelines: B-cell lymphomas version 1.2019
Gopal S, Gross TG (2018) How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa. Blood 132(3):254–263. https://doi.org/10.1182/blood-2018-04-844472
Burggraaff CN, de Jong A, Hoekstra OS et al (2019) Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 46(1):65–79. https://doi.org/10.1007/s00259-018-4103-3
Dunnick NR, Reaman GH, Head GL, Shawker TH, Ziegler JL (1979) Radiographic manifestations of Burkitt’s lymphoma in American patients. AJR Am J Roentgenol 132(1):1–6. https://doi.org/10.2214/ajr.132.1.1
England RJ, Pillay K, Davidson A, Numanoglu A, Millar AJ (2012) Intussusception as a presenting feature of Burkitt lymphoma: implications for management and outcome. Pediatr Surg Int 28(3):267–270. https://doi.org/10.1007/s00383-011-2982-5
Wong S, Sanchez TR, Swischuk LE, Huang FS (2009) Diffuse peritoneal lymphomatosis: atypical presentation of Burkitt lymphoma. Pediatr Radiol 39(3):274–276. https://doi.org/10.1007/s00247-008-1063-y
Kluge R, Kurch L, Montravers F, Mauz-Korholz C (2013) FDG PET/CT in children and adolescents with lymphoma. Pediatr Radiol 43(4):406–417. https://doi.org/10.1007/s00247-012-2559-z
Nzeh DA (1988) Atypical intrathoracic manifestations of Burkitt’s lymphoma. Pediatr Radiol 18(5):411–412
Chan O, Igwe M, Breburda CS, Amar S (2016) Burkitt lymphoma presenting as an intracardiac mass: case report and review of literature. Am J Case Rep 17:553–558
Kobayashi T, Hyodo M, Honda N (2013) Primary endobronchial Burkitt’s lymphoma in a child: a case report. Int J Pediatr Otorhinolaryngol 77(5):875–878. https://doi.org/10.1016/j.ijporl.2013.03.012
Lu R (2012) Primary burkitt lymphoma of the chest wall. Case Rep Hematol 2012:746098. https://doi.org/10.1155/2012/746098
Kaul P, Javangula K (2007) Burkitt lymphoma masquerading as cardiac tamponade. J Cardiothorac Surg 2:30. https://doi.org/10.1186/1749-8090-2-30
Janbabai G, Kayedimajd S, Alian S, Naghshvar F, Rashidi M, Farazmandfar T (2012) Bilateral breast swelling in a 23-year-old woman with Burkitt lymphoma. J Res Med Sci 17(12):1188–1191
Dozzo M, Carobolante F, Donisi PM et al (2017) Burkitt lymphoma in adolescents and young adults: management challenges. Adolesc Health Med Ther 8:11–29. https://doi.org/10.2147/AHMT.S94170
Derinkuyu BE, Boyunaga O, Oztunali C et al (2016) Imaging features of Burkitt lymphoma in pediatric patients. Diagn Interv Radiol 22(1):95–100. https://doi.org/10.5152/dir.2015.15211
Allaoui M, Benchafai I, Mahtat el M et al (2016) Primary Burkitt lymphoma of the thyroid gland: case report of an exceptional type of thyroid neoplasm and review of the literature. BMC Clin Pathol 16:6. https://doi.org/10.1186/s12907-016-0028-6
Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104(10):3009–3020. https://doi.org/10.1182/blood-2004-02-0405
Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059–3068. https://doi.org/10.1200/JCO.2013.54.8800
Song JY, Venkataraman G, Fedoriw Y et al (2016) Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leuk Lymphoma 57(4):866–871. https://doi.org/10.3109/10428194.2015.1085529
Stein JE, Schwenn MR, Jacir NN, Harris BH (1991) Surgical restraint in Burkitt’s lymphoma in children. J Pediatr Surg 26(11):1273–1275
Jacobson C, LaCasce A (2014) How I treat Burkitt lymphoma in adults. Blood 124(19):2913–2920. https://doi.org/10.1182/blood-2014-06-538504
Smeland S, Blystad AK, Kvaloy SO et al (2004) Treatment of Burkitt’s/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian radium hospital with the use of three successive regimens. Ann Oncol 15(7):1072–1078. https://doi.org/10.1093/annonc/mdh262
Ribrag V, Koscielny S, Bosq J et al (2016) Rituximab and dose-dense chemotherapy for adults with Burkitt’s lymphoma: a randomised, controlled, open-label, phase 3 trial. Lancet 387(10036):2402–2411. https://doi.org/10.1016/S0140-6736(15)01317-3
Hill QA, Owen RG (2006) CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev 20(6):319–332. https://doi.org/10.1016/j.blre.2006.02.001
Bernstein JI, Coleman CN, Strickler JG, Dorfman RF, Rosenberg SA (1986) Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt’s and non-Burkitt’s types). J Clin Oncol 4(6):847–858. https://doi.org/10.1200/JCO.1986.4.6.847
Sariban E, Edwards B, Janus C, Magrath I (1983) Central nervous system involvement in American Burkitt’s lymphoma. J Clin Oncol 1(11):677–681. https://doi.org/10.1200/JCO.1983.1.11.677
Eissa HM, Allen CE, Kamdar K et al (2014) Pediatric Burkitt’s lymphoma and diffuse B-cell lymphoma: are surveillance scans required? Pediatr Hematol Oncol 31(3):253–257. https://doi.org/10.3109/08880018.2013.834400
Costa LJ, Xavier AC, Wahlquist AE, Hill EG (2013) Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. Blood 121(24):4861–4866. https://doi.org/10.1182/blood-2012-12-475558
Kim H, Park ES, Lee SH et al (2014) Clinical outcome of relapsed or refractory Burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents. Cancer Res Treat 46(4):358–365. https://doi.org/10.4143/crt.2013.047
Torrisi JM, Schwartz LH, Gollub MJ, Ginsberg MS, Bosl GJ, Hricak H (2011) CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 258(1):41–56. https://doi.org/10.1148/radiol.10092129